Cambridge New Therapeutics Forum

18 May

Open to all scientists researching new therapeutics in Cambridge and the local area.

The purpose of the CamNTF is to promote interactions between scientists from academia & industry in order to improve opportunities for biotechnology research and development. Meeting attendance is free but all attendees must register in advance. The upcoming January event will be hosted by the Office for Translational Research / Maxwell Centre, University of Cambridge

Host: The Babraham Institute, Babraham Research Campus, Cambridge

Date: Wednesday 18th May 2022

Location: This event will be hybrid, with participants able to choose to attend either in person or online. Online joining details will be circulated prior to the event.


17:30-18:00: Welcome, refreshments and networking, The Cambridge Building, Babraham Research Campus, Babraham, Cambridge, CB22 5BZ

18:00 Introduction to the CamNTF: Dr Marc O’Reilly, Vice President, Molecular Sciences, Astex Pharmaceuticals

18:10 Welcome and Introduction to The Babraham Institute: Dr Simon Cook, Interim Director, The Babraham Institute

18:20 Dr Maria Christophorou, Group Leader, The Babraham Institute

Talk title: Novel modulators of peptidylarginine deiminase IV (PADI4), an enzyme deregulated in autoimmunity, cancer and pathologies associated with Neutrophil Extracellular Traps

18:50 Dr Maria Rostovskaya, Senior Research Scientist, The Babraham Institute

Talk title: In vitro-derived human amniotic epithelium for clinical applications

19.05 Dr Caroline Benn, CSO, LoQus23 Therapeutics

Talk title: Drugging DNA damage repair pathways for trinucleotide repeat expansion diseases

Joint Q&A

19:30-20:00 Buffet & networking

20:00 Meeting Close

Venue and Location Information: 
The Babraham Institute, Babraham Research Campus, Cambridge